• HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
  • CONTACT
Type and hit ENTER
  • HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
  • CONTACT
GET CONNECTED
  • HOME
  • ABOUT US
    • CAREERS
  • TECHNOLOGY
  • NEWS
  • SERVICES
    • RESEARCH AND DEVELOPMENT
  • PRODUCTS
  • CONTACT
ProAxsis CEO to present at Biotech in Europe
Share
Conferences, Neutrophil Elastase Immunoassay, News, ProteaseTag®

ProAxsis CEO to present at Biotech in Europe

September 23, 2016
-
Posted by Webmaster

Dr David Ribeiro, CEO of ProAxsis, will be attending the 16th Biotech in Europe Forum, taking place in Basel on September 27th-28th 2016, and will be presenting a company update at 14.10h on September 27th in the Lima room.  The Biotech in Europe Forum is expected to attract more than 600 attendees this year.

Dr Ribeiro said: “ProAxsis continues to make significant progress, with its ProteaseTag® Active Neutrophil Elastase Immunoassay selected for use in several pharmaceutical clinical trials, and further product launches planned in the near future.  Forums such as Biotech in Europe provide ongoing opportunities for us to interact with potential partners and the life sciences community in general.”

Any queries concerning ProAxsis’ Immunoassay for measuring active neutrophil elastase, or any requests for support with measuring other active protease biomarkers using the company’s proprietary ProteaseTag® technology, can be directed to info@77.104.171.207.

ProAxsis is part of the NetScientific group and is one of the group’s core portfolio companies.  The company is also supported by QUBIS, the commercialisation arm of Queens University.

September 23, 2016

Related News

Other posts that you should not miss.
News

ProAxsis featured in Business Eye

September 16, 2016
-
Posted by Webmaster

ProAxsis (www.proaxsis.com) is delighted to have been featured in the latest edition of Business Eye, Northern Ireland’s premium …

Read More
September 16, 2016
Posted by Webmaster
Announcements, News

ProAxsis Limited appoints first distributor for DACH region

December 14, 2020
-
Posted by David Ribeiro

ProAxsis Limited (www.proaxsis.com), the Belfast-based diagnostics company specialising in the measurement of active proteases and other inflammatory …

Read More
December 14, 2020
Posted by David Ribeiro
Announcements, News

ProAxsis Limited supported by Innovate UK to accelerate work on inflammatory biomarkers associated with COVID-19

December 10, 2020
-
Posted by David Ribeiro

ProAxsis (www.proaxsis.com), the Belfast-based respiratory diagnostics company, today announces that it has been awarded a high impact …

Read More
December 10, 2020
Posted by David Ribeiro
← PREVIOUS POST
ProAxsis gains CE Mark for Active Neutrophil Elastase Immunoassay
NEXT POST →
ProAxsis featured in Business Eye
Categories
  • Announcements
  • Conferences
  • NEATstik®
  • Neutrophil Elastase Immunoassay
  • News
  • ProteaseTag®
  • Trials
  • Video
GET CONNECTED
RECENT POSTS
  • ProAxsis signs global in-licensing agreement with AstraZeneca for COVID-19 serology test
    June 7, 2021

    ProAxsis Limited (www.proaxsis.com), the Belfast-based respiratory diagnostics company, is delighted to announce it …

  • ProAxsis Ltd CEO Update Report – May 2021
    May 21, 2021

    Introduction In parallel with the release of the company’s 2020 financial statements, I …

  • ProAxsis Limited enters licensing agreement with top Swiss University as it continues to develop novel new products in the fight against fractures and other metabolic bone diseases
    February 21, 2021

    ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, and a collaboration of the University of …


ProAxsis Ltd
Unit 1B, Concourse Building 3,
Catalyst Inc,
Queen’s Road, Titanic Quarter,
Belfast,
BT3 9DT,
Northern Ireland

tel +44 (0)28 9073 0444
email info@proaxsis.com

RECENT NEWS
  • May 17, 2022
    Belfast Telegraph Awards
  • May 16, 2022
    ProAxsis announces “impressive” results in Performance Evaluation of COVID-19 antibody test
  • January 31, 2022
    ProAxsis enhances availability of product portfolio in Asia via new partnership with Kyberlife
Copyright © 2016-2021 - ProAxsis - All rights reserved. 
ProAxsis CEO to present at Biotech in Europe - ProAxsis